cmv Antibody
cmv Antibody
CMV Control lentiviral particles (Puro) |
|||
| CMV-Null-Puro | GenTarget | 1 x107 IFU/ml x 200ul | 349 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. |
|||
CMV Control lentiviral particles (GFP-Bsd) |
|||
| CMV-Null-GB | GenTarget | 1 x107 IFU/ml x 200ul | 349 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Blasticidin fusion marker under RSV promoter. |
|||
CMV Control lentiviral particles (GFP-Puro) |
|||
| CMV-Null-GP | GenTarget | 1 x107 IFU/ml x 200ul | 349 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. |
|||
CMV Control lentiviral particles (RFP-Bsd) |
|||
| CMV-Null-RB | GenTarget | 1 x107 IFU/ml x 200ul | 349 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter. |
|||
CMV Control lentiviral particles (RFP-Puro) |
|||
| CMV-Null-RP | GenTarget | 1 x107 IFU/ml x 200ul | 349 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. |
|||
CMV Control lentiviral particles (Bsd) in PBS |
|||
| CMV-Null-Bsd-PBS | GenTarget | 1 x108 IFU/ml x 200ul | 710 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the blasticidin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
CMV Control lentiviral particles (Neo) in PBS |
|||
| CMV-Null-Neo-PBS | GenTarget | 1 x108 IFU/ml x 200ul | 710 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
CMV Control lentiviral particles (Puro) in PBS |
|||
| CMV-Null-Puro-PBS | GenTarget | 1 x108 IFU/ml x 200ul | 710 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
CMV Control lentiviral particles (GFP-Bsd) in PBS |
|||
| CMV-Null-GB-PBS | GenTarget | 1 x108 IFU/ml x 200ul | 710 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
CMV Control lentiviral particles (GFP-Puro) in PBS |
|||
| CMV-Null-GP-PBS | GenTarget | 1 x108 IFU/ml x 200ul | 710 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
CMV Control lentiviral particles (RFP-Bsd) in PBS |
|||
| CMV-Null-RB-PBS | GenTarget | 1 x108 IFU/ml x 200ul | 710 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
CMV Control lentiviral particles (RFP-Puro) in PBS |
|||
| CMV-Null-RP-PBS | GenTarget | 1 x108 IFU/ml x 200ul | 710 EUR |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
CMV Antibody |
|||
| abx021636-1mg | Abbexa | 1 mg | 599 EUR |
CMV Antibody |
|||
| abx021637-1mg | Abbexa | 1 mg | 1372 EUR |
CMV Antibody |
|||
| abx021638-1mg | Abbexa | 1 mg | 1205 EUR |
CMV Antibody |
|||
| abx021639-1mg | Abbexa | 1 mg | 2332 EUR |
CMV Antibody |
|||
| abx021640-100ug | Abbexa | 100 ug | 662 EUR |
CMV Antibody |
|||
| abx021641-1mg | Abbexa | 1 mg | 1567 EUR |
CMV Antibody |
|||
| abx021642-100ug | Abbexa | 100 ug | 592 EUR |
CMV Antibody |
|||
| abx021643-100ug | Abbexa | 100 ug | 662 EUR |
CMV Antibody |
|||
| abx022961-1ml | Abbexa | 1 ml | 732 EUR |
CMV antibody |
|||
| 10-1439 | Fitzgerald | 200 ug | 692 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50C | Fitzgerald | 200 ug | 692 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50D | Fitzgerald | 200 ug | 692 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50F | Fitzgerald | 200 ug | 692 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50G | Fitzgerald | 200 ug | 692 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50L | Fitzgerald | 1 mg | 138 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50M | Fitzgerald | 1 mg | 133 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50N | Fitzgerald | 1 mg | 133 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50P | Fitzgerald | 200 ug | 732 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10-C50R | Fitzgerald | 200 ug | 241 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10C-CR1294M1 | Fitzgerald | 100 ug | 358 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10C-CR2126M1 | Fitzgerald | 200 ug | 624 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 10R-C180a | Fitzgerald | 1 mg | 447 EUR |
|
Description: Mouse monoclonal CMV antibody |
|||
CMV antibody |
|||
| 20-CG70 | Fitzgerald | 1 mg | 116 EUR |
|
Description: Goat polyclonal CMV antibody |
|||
Anti-CMV antibody |
|||
| STJ180079 | St John's Laboratory | 0.1 ml | 212 EUR |
CMV ICP36 antibody |
|||
| 10-C50I | Fitzgerald | 100 ug | 274 EUR |
|
Description: Mouse monoclonal CMV ICP36 antibody |
|||
CMV pp65 antibody |
|||
| 10-C50K | Fitzgerald | 200 ug | 369 EUR |
|
Description: Mouse monoclonal CMV pp65 antibody |
|||
CMV antibody (FITC) |
|||
| 60-C69 | Fitzgerald | 1 ml | 336 EUR |
|
Description: Goat polyclonal CMV antibody (FITC) conjugated |
|||
CMV antibody (HRP) |
|||
| 60-C70 | Fitzgerald | 1 ml | 400 EUR |
|
Description: Goat polyclonal CMV antibody (HRP) conjugated |
|||
CMV antibody (biotin) |
|||
| 60C-CR2126GB | Fitzgerald | 1 ml | 363 EUR |
|
Description: Goat polyclonal CMV antibody (biotin) conjugated |
|||
CMV gB antibody |
|||
| 10R-H106a | Fitzgerald | 100 ug | 349 EUR |
|
Description: Mouse monoclonal CMV gB antibody |
|||
CMV-p65(CMV100) Antibody |
|||
| BNCA0100-250 | Biotium | 250uL | 383 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), APC conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNCA0101-250 | Biotium | 250uL | 383 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), APC conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNCAP0100-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNCAP0100-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNCAP0101-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNCAP0101-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNC810100-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNC810100-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNC810101-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNC810101-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNC880100-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNC880100-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNC880101-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNC880101-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNCB0100-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNCB0100-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNCB0101-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNCB0101-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNC550100-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNC550100-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNC550101-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNC550101-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNC470100-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNC470100-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNC470101-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV101) Antibody |
|||
| BNC470101-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CMV-p65(CMV101), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNC940100-100 | Biotium | 100uL | 199 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CMV-p65(CMV100) Antibody |
|||
| BNC940100-500 | Biotium | 500uL | 544 EUR |
|
Description: Primary antibody against CMV-p65(CMV100), CF594 conjugate, Concentration: 0.1mg/mL |
|||